1. Home
  2. GKOS vs LTH Comparison

GKOS vs LTH Comparison

Compare GKOS & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • LTH
  • Stock Information
  • Founded
  • GKOS 1998
  • LTH 1992
  • Country
  • GKOS United States
  • LTH United States
  • Employees
  • GKOS N/A
  • LTH N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • LTH Hotels/Resorts
  • Sector
  • GKOS Health Care
  • LTH Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • LTH Nasdaq
  • Market Cap
  • GKOS 5.4B
  • LTH 6.4B
  • IPO Year
  • GKOS 2015
  • LTH 2021
  • Fundamental
  • Price
  • GKOS $82.38
  • LTH $28.02
  • Analyst Decision
  • GKOS Strong Buy
  • LTH Buy
  • Analyst Count
  • GKOS 12
  • LTH 11
  • Target Price
  • GKOS $128.58
  • LTH $35.50
  • AVG Volume (30 Days)
  • GKOS 698.2K
  • LTH 1.9M
  • Earning Date
  • GKOS 11-03-2025
  • LTH 10-23-2025
  • Dividend Yield
  • GKOS N/A
  • LTH N/A
  • EPS Growth
  • GKOS N/A
  • LTH 93.31
  • EPS
  • GKOS N/A
  • LTH 1.03
  • Revenue
  • GKOS $432,953,000.00
  • LTH $2,824,027,000.00
  • Revenue This Year
  • GKOS $28.79
  • LTH $14.61
  • Revenue Next Year
  • GKOS $25.65
  • LTH $10.85
  • P/E Ratio
  • GKOS N/A
  • LTH $27.01
  • Revenue Growth
  • GKOS 26.70
  • LTH 17.25
  • 52 Week Low
  • GKOS $77.10
  • LTH $21.49
  • 52 Week High
  • GKOS $163.71
  • LTH $34.99
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 35.40
  • LTH 46.68
  • Support Level
  • GKOS $80.52
  • LTH $28.14
  • Resistance Level
  • GKOS $95.32
  • LTH $29.49
  • Average True Range (ATR)
  • GKOS 2.82
  • LTH 0.68
  • MACD
  • GKOS -1.23
  • LTH 0.01
  • Stochastic Oscillator
  • GKOS 11.29
  • LTH 34.67

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About LTH Life Time Group Holdings Inc.

Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.

Share on Social Networks: